Literature DB >> 10432683

A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.

A Matsuda1, M Fukushima, Y Wataya, T Sasaki.   

Abstract

The antitumor activity, metabolism, and mechanism of action of a newly developed antitumor nucleoside, 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd) are described.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10432683     DOI： 10.1080/15257779908041568

Source DB:  PubMed          Journal:  Nucleosides Nucleotides        ISSN： 0732-8311


  3 in total

1.  Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.

Authors:  Yuji Shimamoto; Hiromi Kazuno; Yuko Murakami; Atsushi Azuma; Katsuhisa Koizumi; Akira Matsuda; Takuma Sasaki; Masakazu Fukushima
Journal:  Jpn J Cancer Res       Date:  2002-04

2.  Synthesis and Cytostatic Effect of 3'-deoxy-3'-C-Sulfanylmethyl Nucleoside Derivatives with d-xylo Configuration.

Authors:  Miklós Bege; Alexandra Kiss; Máté Kicsák; Ilona Bereczki; Viktória Baksa; Gábor Király; Gábor Szemán-Nagy; M Zsuzsa Szigeti; Pál Herczegh; Anikó Borbás
Journal:  Molecules       Date:  2019-06-10       Impact factor: 4.411

3.  Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2.

Authors:  Yuji Shimamoto; Katsuhisa Koizumi; Hiroyuki Okabe; Hiromi Kazuno; Yuko Murakami; Fumio Nakagawa; Akira Matsuda; Takuma Sasaki; Masakazu Fukushima
Journal:  Jpn J Cancer Res       Date:  2002-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.